These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 38698565

  • 1. Albuterol-budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study.
    Papi A, Chipps BE, Beasley R, Panettieri RA, Israel E, Cooper M, Dunsire L, Jeynes-Ellis A, Rees R, Albers FC, Cappelletti C.
    Ther Adv Respir Dis; 2024; 18():17534666241232264. PubMed ID: 38698565
    [Abstract] [Full Text] [Related]

  • 2. Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.
    Papi A, Chipps BE, Beasley R, Panettieri RA, Israel E, Cooper M, Dunsire L, Jeynes-Ellis A, Johnsson E, Rees R, Cappelletti C, Albers FC.
    N Engl J Med; 2022 Jun 02; 386(22):2071-2083. PubMed ID: 35569035
    [Abstract] [Full Text] [Related]

  • 3. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD, Patrick DL, Parasuraman B, Martin P, Goldman M.
    J Asthma; 2010 Mar 02; 47(2):217-23. PubMed ID: 20170333
    [Abstract] [Full Text] [Related]

  • 4. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.
    Kew KM, Karner C, Mindus SM, Ferrara G.
    Cochrane Database Syst Rev; 2013 Dec 16; 2013(12):CD009019. PubMed ID: 24343671
    [Abstract] [Full Text] [Related]

  • 5. Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.
    Knox SK, Mahr TA.
    Pediatrics; 2023 Dec 01; 152(Suppl 3):S52. PubMed ID: 38038518
    [No Abstract] [Full Text] [Related]

  • 6. Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthma.
    Pilcher J, Patel M, Smith A, Davies C, Pritchard A, Travers J, Black P, Weatherall M, Beasley R, Harwood M, SMART Study Group.
    Respirology; 2014 Aug 01; 19(6):842-51. PubMed ID: 24889937
    [Abstract] [Full Text] [Related]

  • 7. [Powder inhaler with integrated motor. The anti-asthmatic drug stays fresh].
    MMW Fortschr Med; 2001 Apr 19; 143(16):58. PubMed ID: 11367998
    [No Abstract] [Full Text] [Related]

  • 8. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
    Vogelmeier C, Naya I, Ekelund J.
    Clin Drug Investig; 2012 Jul 01; 32(7):439-49. PubMed ID: 22607479
    [Abstract] [Full Text] [Related]

  • 9. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
    Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO.
    Respir Med; 1999 Dec 01; 93(12):876-84. PubMed ID: 10653049
    [Abstract] [Full Text] [Related]

  • 10. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C, Wu EQ, Ray S, Colice GL.
    Clin Ther; 2009 Dec 01; 31(12):2779-803. PubMed ID: 20110019
    [Abstract] [Full Text] [Related]

  • 11. Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study.
    Aalbers R.
    Clin Drug Investig; 2010 Dec 01; 30(7):439-51. PubMed ID: 20528000
    [Abstract] [Full Text] [Related]

  • 12. Call for withdrawal of LABA single-therapy inhaler in asthma.
    Beasley R, Perrin K, Weatherall M, Wijesinghe M.
    Lancet; 2010 Sep 04; 376(9743):750-1. PubMed ID: 20816529
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
    Busse WW, Shah SR, Somerville L, Parasuraman B, Martin P, Goldman M.
    J Allergy Clin Immunol; 2008 Jun 04; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
    [Abstract] [Full Text] [Related]

  • 14. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.
    Cates CJ, Karner C.
    Cochrane Database Syst Rev; 2013 Apr 30; 2013(4):CD007313. PubMed ID: 23633340
    [Abstract] [Full Text] [Related]

  • 15. [Do fixed combinations increase effectiveness in asthma bronchiale?].
    Vogelmeier C.
    Dtsch Med Wochenschr; 2009 Dec 30; 134 Suppl 10():S372-5. PubMed ID: 19941239
    [No Abstract] [Full Text] [Related]

  • 16. Budesonide/formoterol in the treatment of asthma.
    Hodgson D, Mortimer K, Harrison T.
    Expert Rev Respir Med; 2010 Oct 30; 4(5):557-66. PubMed ID: 20923335
    [Abstract] [Full Text] [Related]

  • 17. Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol.
    Blais L, Beauchesne MF, Forget A.
    Respir Med; 2009 Feb 30; 103(2):237-43. PubMed ID: 18930647
    [Abstract] [Full Text] [Related]

  • 18. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.
    Papi A, Canonica GW, Maestrelli P, Paggiaro P, Olivieri D, Pozzi E, Crimi N, Vignola AM, Morelli P, Nicolini G, Fabbri LM, BEST Study Group.
    N Engl J Med; 2007 May 17; 356(20):2040-52. PubMed ID: 17507703
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C.
    Curr Med Res Opin; 2004 Sep 17; 20(9):1403-18. PubMed ID: 15383189
    [Abstract] [Full Text] [Related]

  • 20. Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.
    Kamin W, Schwabe A, Krämer I.
    J Cyst Fibros; 2006 Dec 17; 5(4):205-13. PubMed ID: 16678502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.